24 Feb 2014
(MENAFN) Julphar, Ras Al Khaimah-based pharmaceutical products producer and distributor, reported a 14.9 percent growth in net profit of 2013 to reach USD62.71 million, according to the Emirates 24/7.
The company also reported a 15.4 percent growth in revenue year-on-year to reach USD3707 million.
Sales boosted by 19.4 percent year-on-year in 2013 driven by the private market sales.
Julphar Chairman, Sheikh Faisal Bin Saqr Al Qassimi, said: “The UAE is driving forward healthcare expansion at an international level and Julphar is proud to play a significant role in shaping the future of our industry. As the first and largest Emirati Pharmaceutical Company, we are positioned to help create a truly global platform for quality healthcare.”
17 Nov 2024
BBK and Asia Jewellers announce exclusive offers to its customers at Jewellery Arabia 2024
12 Nov 2024
BBK partners with Durrat Al Bahrain to offer exclusive financing for Jawhart Al Marjan
05 Nov 2024
As part of its digital transformation journey, BBK adds Google Wallet to its range of digital wallets
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more